Skip to main content

Advertisement

SpringerLink
Log in

Catalpol Promotes the Survival and VEGF Secretion of Bone Marrow-Derived Stem Cells and Their Role in Myocardial Repair After Myocardial Infarction in Rats

  • Published:
Cardiovascular Toxicology Aims and scope Submit manuscript

Abstract

Bone mesenchymal stem cells (BMSCs) transplantation has been recognized as an effective method for the treatment of myocardial infarction (MI). However, its efficacy is always restricted by the low survival of transplanted BMSCs in the ischemic myocardium. The aim of this study was to investigate the effect of catalpol pre-treatment on the survival and vascular endothelial growth factor (VEGF) secretion of BMSCs under oxygen glucose deprivation (OGD) condition and their role in myocardial repair in a rat model of MI. According to our results, pre-treatment with catalpol enhanced VEGF secretion and survival of OGD-treated BMSCs. Moreover, the apoptosis of BMSCs induced by OGD was restrained by catalpol as evidenced by increased level of B-cell lymphoma-2 (Bcl-2) and decreased levels of BCL2-associated X (Bax) and cleaved caspase-3. In vivo study suggested that the survival of transplanted BMSCs was improved by catalpol pre-treatment. The myocardial fibrosis and apoptosis was further inhibited in catalpol pre-treated BMSCs group. Cardiac function detected by echocardiography was obviously improved by catalpol pre-treated BMSCs transplantation. Finally, angiogenesis and VEGF expression in the ischemic myocardium were significantly promoted in catalpol pre-treated BMSCs group. In conclusion, catalpol pre-treatment may facilitate the survival and VEGF secretion of BMSCs and improve their therapeutic effect on MI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Wu, Z., Chen, G., Zhang, J., Hua, Y., Li, J., Liu, B., Huang, A., Li, H., Chen, M., & Ou, C. (2017). Treatment of myocardial infarction with gene-modified mesenchymal stem cells in a small molecular hydrogel. Scientific Reports, 7, 15826.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Deluyker, D., Ferferieva, V., Driesen, R. B., Verboven, M., Lambrichts, I., & Bito, V. (2017). Pyridoxamine improves survival and limits cardiac dysfunction after MI. Scientific Reports, 7, 16010.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Elmadbouh, I., & Ashraf, M. (2017). Tadalafil, a long acting phosphodiesterase inhibitor, promotes bone marrow stem cell survival and their homing into ischemic myocardium for cardiac repair. Physiological Reports 5, e13480.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Amado, L. C., Saliaris, A. P., Schuleri, K. H., St John, M., Xie, J. S., Cattaneo, S., Durand, D. J., Fitton, T., Kuang, J. Q., Stewart, G., Lehrke, S., Baumgartner, W. W., Martin, B. J., Heldman, A. W., & Hare, J. M. (2005). Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proceedings of the National Academy of Sciences of the United States of America, 102, 11474–11479.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Zhang, G. W., Gu, T. X., Guan, X. Y., Sun, X. J., Qi, X., Li, X. Y., Wang, X. B., Lv, F., Yu, L., Jiang, D. Q., & Tang, R. (2015). HGF and IGF-1 promote protective effects of allogeneic BMSC transplantation in rabbit model of acute myocardial infarction. Cell Proliferation, 48, 661–670.

    Article  PubMed  CAS  Google Scholar 

  6. Gao, L. R., Pei, X. T., Ding, Q. A., Chen, Y., Zhang, N. K., Chen, H. Y., Wang, Z. G., Wang, Y. F., Zhu, Z. M., Li, T. C., Liu, H. L., Tong, Z. C., Yang, Y., Nan, X., Guo, F., Shen, J. L., Shen, Y. H., Zhang, J. J., Fei, Y. X., Xu, H. T., Wang, L. H., Tian, H. T., & Liu, D. Q. (2013). A critical challenge: Dosage-related efficacy and acute complication intracoronary injection of autologous bone marrow mesenchymal stem cells in acute myocardial infarction. International Journal of Cardiology, 168, 3191–3199.

    Article  PubMed  Google Scholar 

  7. Zhang, H., Hou, J. F., Shen, Y., Wang, W., Wei, Y. J., & Hu, S. (2010). Low level laser irradiation precondition to create friendly milieu of infarcted myocardium and enhance early survival of transplanted bone marrow cells. Journal of Cellular and Molecular Medicine, 14, 1975–1987.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Gao, X. R., Xu, H. J., Wang, L. F., Liu, C. B., & Yu, F. (2017). Mesenchymal stem cell transplantation carried in SVVYGLR modified self-assembling peptide promoted cardiac repair and angiogenesis after myocardial infarction. Biochemical and Biophysical Research Communications, 491, 112–118.

    Article  PubMed  CAS  Google Scholar 

  9. Carmeliet, P. (2005). Angiogenesis in life, disease and medicine. Nature, 438, 932–936.

    Article  PubMed  CAS  Google Scholar 

  10. Xia, J. B., Wu, H. Y., Lai, B. L., Zheng, L., Zhou, D. C., Chang, Z. S., Mao, C. Z., Liu, G. H., Park, K. S., Zhao, H., Kim, S. K., Song, G. H., Cai, D. Q., & Qi, X. F. (2017). Gene delivery of hypoxia-inducible VEGF targeting collagen effectively improves cardiac function after myocardial infarction. Scientific Reports, 7, 13273.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Gao, F., He, T., Wang, H., Yu, S., Yi, D., Liu, W., & Cai, Z. (2007). A promising strategy for the treatment of ischemic heart disease: Mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats. Canadian Journal of Cardiology, 23, 891–898.

    Article  PubMed  Google Scholar 

  12. Shieh, J. P., Cheng, K. C., Chung, H. H., Kerh, Y. F., Yeh, C. H., & Cheng, J. T. (2011). Plasma glucose lowering mechanisms of catalpol, an active principle from roots of Rehmannia glutinosa, in streptozotocin-induced diabetic rats. Journal of Agricultural and Food Chemistry, 59, 3747–3753.

    Article  PubMed  CAS  Google Scholar 

  13. Zhang, X., Zhang, A., Jiang, B., Bao, Y., Wang, J., & An, L. (2008). Further pharmacological evidence of the neuroprotective effect of catalpol from Rehmannia glutinosa. Phytomedicine, 15, 484–490.

    Article  PubMed  CAS  Google Scholar 

  14. Shen, C. Y., Jiang, J. G., Yang, L., Wang, D. W., & Zhu, W. (2017). Anti-ageing active ingredients from herbs and nutraceuticals used in traditional Chinese medicine: Pharmacological mechanisms and implications for drug discovery. British Journal of Pharmacology, 174, 1395–1425.

    Article  PubMed  CAS  Google Scholar 

  15. Wang, L., & Xue, G. B. (2018). Catalpol suppresses osteosarcoma cell proliferation through blocking epithelial-mesenchymal transition (EMT) and inducing apoptosis. Biochemical and Biophysical Research Communications, 495, 27–34.

    Article  PubMed  CAS  Google Scholar 

  16. Dong, W., Xian, Y., Yuan, W., Huifeng, Z., Tao, W., Zhiqiang, L., Shan, F., Ya, F., Hongli, W., Jinghuan, W., Lei, Q., Li, Z., & Hongyi, Q. (2016). Catalpol stimulates VEGF production via the JAK2/STAT3 pathway to improve angiogenesis in rats’ stroke model. Journal of Ethnopharmacology, 191, 169–179.

    Article  PubMed  CAS  Google Scholar 

  17. Hu, L. A., Sun, Y. K., Zhang, H. S., Zhang, J. G., & Hu, J. (2016). Catalpol inhibits apoptosis in hydrogen peroxide-induced cardiac myocytes through a mitochondrial-dependent caspase pathway. Bioscience Reports 36, e00348.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Chen, W., Li, X., Jia, L. Q., Wang, J., Zhang, L., Hou, D., & Ren, L. (2013). Neuroprotective activities of catalpol against CaMKII-dependent apoptosis induced by LPS in PC12 cells. British Journal of Pharmacology, 169, 1140–1152.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Li, L., Guan, Q., Dai, S., Wei, W., & Zhang, Y. (2017). Integrin beta1 increases stem cell survival and cardiac function after myocardial infarction. Frontiers in Pharmacology, 8, 135.

    PubMed  PubMed Central  Google Scholar 

  20. Minguell, J. J., & Erices, A. (2006). Mesenchymal stem cells and the treatment of cardiac disease. Experimental Biology and Medicine, 231, 39–49.

    Article  PubMed  CAS  Google Scholar 

  21. Schuleri, K. H., Feigenbaum, G. S., Centola, M., Weiss, E. S., Zimmet, J. M., Turney, J., Kellner, J., Zviman, M. M., Hatzistergos, K. E., Detrick, B., Conte, J. V., McNiece, I., Steenbergen, C., Lardo, A. C., & Hare, J. M. (2009). Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. European Heart Journal, 30, 2722–2732.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Liu, X., Hou, J., Shi, L., Chen, J., Sang, J., Hu, S., Cong, X., & Chen, X. (2009). Lysophosphatidic acid protects mesenchymal stem cells against ischemia-induced apoptosis in vivo. Stem Cells and Development, 18, 947–954.

    Article  PubMed  CAS  Google Scholar 

  23. Khan, I., Ali, A., Akhter, M. A., Naeem, N., Chotani, M. A., Mustafa, T., & Salim, A. (2016). Preconditioning of mesenchymal stem cells with 2,4-dinitrophenol improves cardiac function in infarcted rats. Life Sciences, 162, 60–69.

    Article  PubMed  CAS  Google Scholar 

  24. Meng, X., Li, J., Yu, M., Yang, J., Zheng, M., Zhang, J., Sun, C., Liang, H., & Liu, L. (2018). Transplantation of mesenchymal stem cells overexpressing IL10 attenuates cardiac impairments in rats with myocardial infarction. Journal of Cellular Physiology, 233, 587–595.

    Article  PubMed  CAS  Google Scholar 

  25. Kim, H. W., Haider, H. K., Jiang, S., & Ashraf, M. (2009). Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. Journal of Biological Chemistry, 284, 33161–33168.

    Article  PubMed  CAS  Google Scholar 

  26. Wang, Z., An, L. J., Duan, Y. L., Li, Y. C., & Jiang, B. (2008). Catalpol protects rat pheochromocytoma cells against oxygen and glucose deprivation-induced injury. Neurological Research, 30, 106–112.

    Article  PubMed  Google Scholar 

  27. Hu, L., Sun, Y., & Hu, J. (2010). Catalpol inhibits apoptosis in hydrogen peroxide-induced endothelium by activating the PI3K/Akt signaling pathway and modulating expression of Bcl-2 and Bax. European Journal of Pharmacology, 628, 155–163.

    Article  PubMed  CAS  Google Scholar 

  28. Chen, C., Chen, Z., Xu, F., Zhu, C., Fang, F., Shu, S., Li, M., & Ling, C. (2013). Radio-protective effect of catalpol in cultured cells and mice. Journal of Radiation Research, 54, 76–82.

    Article  PubMed  CAS  Google Scholar 

  29. Cai, Q., Yao, Z., & Li, H. (2014). Catalpol promotes oligodendrocyte survival and oligodendrocyte progenitor differentiation via the Akt signaling pathway in rats with chronic cerebral hypoperfusion. Brain Research, 1560, 27–35.

    Article  PubMed  CAS  Google Scholar 

  30. Labi, V., Grespi, F., Baumgartner, F., & Villunger, A. (2008). Targeting the Bcl-2-regulated apoptosis pathway by BH3 mimetics: A breakthrough in anticancer therapy? Cell Death & Differentiation, 15, 977–987.

    Article  CAS  Google Scholar 

  31. Porter, A. G., & Janicke, R. U. (1999). Emerging roles of caspase-3 in apoptosis. Cell Death & Differentiation, 6, 99–104.

    Article  CAS  Google Scholar 

  32. Cohn, J. N., Ferrari, R., & Sharpe, N. (2000). Cardiac remodeling—Concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. Journal of the American College of Cardiology, 35, 569–582.

    Article  PubMed  CAS  Google Scholar 

  33. Abbate, A., Biondi-Zoccai, G. G., Bussani, R., Dobrina, A., Camilot, D., Feroce, F., Rossiello, R., Baldi, F., Silvestri, F., Biasucci, L. M., & Baldi, A. (2003). Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. Journal of the American College of Cardiology, 41, 753–760.

    Article  PubMed  Google Scholar 

  34. Rahbarghazi, R., Nassiri, S. M., Ahmadi, S. H., Mohammadi, E., Rabbani, S., Araghi, A., & Hosseinkhani, H. (2014). Dynamic induction of pro-angiogenic milieu after transplantation of marrow-derived mesenchymal stem cells in experimental myocardial infarction. International Journal of Cardiology, 173, 453–466.

    Article  PubMed  Google Scholar 

  35. Nor, J. E., Christensen, J., Mooney, D. J., & Polverini, P. J. (1999). Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. The American Journal of Pathology, 154, 375–384.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Zhu, H. F., Wan, D., Luo, Y., Zhou, J. L., Chen, L., & Xu, X. Y. (2010). Catalpol increases brain angiogenesis and up-regulates VEGF and EPO in the rat after permanent middle cerebral artery occlusion. International Journal of Biological Sciences, 6, 443–453.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Shengjing Hospital of China Medical University, 36 Sanhao Street, Shenyang, 110004, Liaoning, People’s Republic of China

    Xing’ai Ju & Zhanquan Li

  2. Department of Emergency Medicine, The People’s Hospital of Liaoning Province, Shenyang, 110016, Liaoning, People’s Republic of China

    Xing’ai Ju, Tongyi Wang, Baiping Ge & Yu Zhang

  3. Comprehensive Circulation Ward, The General Hospital of Fushun Mining Affairs Bureau, Fushun, 113008, Liaoning, People’s Republic of China

    Degang Xue

Authors
  1. Xing’ai Ju
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Degang Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tongyi Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Baiping Ge
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yu Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zhanquan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhanquan Li.

Ethics declarations

Conflict of interest

We declare that there is no competing financial interest for this work.

Additional information

Handling Editor: Gen Suzuki

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ju, X., Xue, D., Wang, T. et al. Catalpol Promotes the Survival and VEGF Secretion of Bone Marrow-Derived Stem Cells and Their Role in Myocardial Repair After Myocardial Infarction in Rats. Cardiovasc Toxicol 18, 471–481 (2018). https://doi.org/10.1007/s12012-018-9460-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12012-018-9460-4

Keywords

Search

Navigation